9.61
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RCEL?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$9.10
Offen:
$9.3
24-Stunden-Volumen:
134.46K
Relative Volume:
0.68
Marktkapitalisierung:
$243.28M
Einnahmen:
$50.14M
Nettoeinkommen (Verlust:
$-35.38M
KGV:
-6.8643
EPS:
-1.4
Netto-Cashflow:
$-39.46M
1W Leistung:
+4.12%
1M Leistung:
+7.25%
6M Leistung:
-9.68%
1J Leistung:
+12.40%
Avita Medical Inc Stock (RCEL) Company Profile
Firmenname
Avita Medical Inc
Sektor
Branche
Telefon
661-568-1317
Adresse
28159 AVENUE STANFORD, VALENCIA, CA
Vergleichen Sie RCEL mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
RCEL
Avita Medical Inc
|
9.61 | 243.28M | 50.14M | -35.38M | -39.46M | -1.40 |
![]()
ABT
Abbott Laboratories
|
131.73 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
95.05 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
348.12 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
83.37 | 106.90B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
70.60 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-12-24 | Eingeleitet | D. Boral Capital | Buy |
2024-04-11 | Herabstufung | BTIG Research | Buy → Neutral |
2023-06-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
2021-03-02 | Eingeleitet | Piper Sandler | Overweight |
2020-08-27 | Eingeleitet | BofA Securities | Buy |
2020-04-21 | Eingeleitet | Oppenheimer | Outperform |
2020-03-03 | Eingeleitet | BTIG Research | Buy |
Alle ansehen
Avita Medical Inc Aktie (RCEL) Neueste Nachrichten
Avita Uses Its Tech To Treat Wounds - Los Angeles Business Journal
AVITA Medical to Announce First Quarter 2025 Financial Results - The Manila Times
AVITA Medical to Announce First Quarter 2025 Financial Results | RCEL Stock News - GuruFocus
Leading Wound Care Company AVITA Medical Announces Q1 2025 Earnings Call Details - Stock Titan
The new medical device company to watch - Morningstar
AVITA Medical, Inc. Announces Chief Executive Officer Changes - marketscreener.com
AVITA Medical, Inc.'s (NASDAQ:RCEL) Profit Outlook - simplywall.st
AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025 | RCEL Stock News - GuruFocus
AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025 - The Manila Times
AVITA Medical (NASDAQ:RCEL) Receives "Buy" Rating from D. Boral Capital - MarketBeat
Major Clinical Breakthrough: New Data From 6,000 Patients Transforms Burn Treatment - Stock Titan
6 Analysts Assess AVITA Medical: What You Need To Know - Benzinga
AVITA Medical Announces US Commercial Launch Of Cohealyx - marketscreener.com
Avita Medical's Cohealyx Wound Treatment Makes Commercial Launch in US; Shares Down 4% - MarketScreener
AVITA Medical launches Cohealyx in the U.S. market By Investing.com - Investing.com South Africa
AVITA Medical Launches Wound Care Product Cohealyx in US - MarketScreener
AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity - The Manila Times
AVITA Medical launches Cohealyx in the U.S. market - Investing.com
Game-Changing Wound Care: AVITA's New Cohealyx Shows Superior Healing Results - Stock Titan
Avita Medical stock hits 52-week low at $7.44 amid market challenges - Investing.com Canada
Long Term Trading Analysis for (RCEL) - news.stocktradersdaily.com
Does Avita Medical (RCEL) Have the Potential to Rally 73.72% as Wall Street Analysts Expect? - MSN
Short Interest in AVITA Medical, Inc. (NASDAQ:RCEL) Grows By 35.8% - MarketBeat
AVITA Medical (NASDAQ:RCEL) Earns "Buy" Rating from D. Boral Capital - MarketBeat
Investors overly negative on undervalued ASX share - Morningstar.com.au
Global healthcare stocks for your watchlist - Morningstar Australia
AVITA Medical’s SWOT analysis: regenerative medicine stock faces growth hurdles - Investing.com
AVITA Medical signs manufacturing deal with Stedical Scientific for PermeaDerm - MSN
AVITA Medical (NASDAQ:RCEL) Receives “Buy” Rating from D. Boral Capital - Defense World
What Analysts Are Saying About AVITA Medical Stock - Benzinga
AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific - The Manila Times
AVITA Secures Manufacturing, Amends Distribution Agreement with US-Based Healthcare Tech Provider; Shares Rise 7% - Marketscreener.com
AVITA Medical (ASX:AVH) Announces New Manufacturing and Distribution Agreements - The Capital Club
Avita Medical Boosts Production with New Agreement - TipRanks
(RCEL) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Skin Burns Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Drugs Market, Prevalence, Medication, Statistics, Therapies, Companies by DelveInsight - The Globe and Mail
Investors Don't See Light At End Of AVITA Medical, Inc.'s (NASDAQ:RCEL) Tunnel - Simply Wall St
How To Trade (RCEL) - Stock Traders Daily
Avita Medical LimitedADR to Host Earnings Call - ACCESS Newswire
AVITA Medical to Present at TD Cowen's 45ᵗʰ Annual Health Care Conference - The Manila Times
Can AVITA Medical's Conference Appearance Signal New Growth Opportunities in Wound Care? - StockTitan
Burns Pipeline 2024: Therapies, MOA Insights, and Key Clinical - openPR
AVITA Medical to Present at TD Cowen’s 45ᵗʰ Annual Health Care Conference - Yahoo Finance
D. Boral Capital Lowers AVITA Medical (NASDAQ:RCEL) Price Target to $22.00 - MarketBeat
AVITA Medical (RCEL) to Release Quarterly Earnings on Thursday - MarketBeat
Insider Buying: Robert Mcnamara Acquires 10,000 Shares of AVITA Medical Inc (RCEL) - GuruFocus.com
Finanzdaten der Avita Medical Inc-Aktie (RCEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):